Abstract:TIAM2S, the short form of human T‐cell lymphoma invasion and metastasis 2, can have oncogenic effects when aberrantly expressed in the liver or lungs. However, it is also abundant in healthy, non‐neoplastic brain tissue, in which its primary function is still unknown. Here, we examined the neurobiological and behavioral significance of human TIAM2S using the human brain protein panels, a human NT2/D1‐derived neuronal cell line model (NT2/N), and transgenic mice that overexpress human TIAM2S (TIAM2S‐TG). Our data reveal that TIAM2S exists primarily in neurons of the restricted brain areas around the limbic system and in well‐differentiated NT2/N cells. Functional studies revealed that TIAM2S has no guanine nucleotide exchange factor (GEF) activity and is mainly located in the nucleus. Furthermore, whole‐transcriptome and enrichment analysis with total RNA sequencing revealed that TIAM2S‐knockdown (TIAM2S‐KD) was strongly associated with the cellular processes of the brain structural development and differentiation, serotonin‐related signaling, and the diseases markers representing neurobehavioral developmental disorders. Moreover, TIAM2S‐KD cells display decreased neurite outgrowth and reduced serotonin levels. Moreover, TIAM2S overexpressing TG mice show increased number and length of serotonergic fibers at early postnatal stage, results in higher serotonin levels at both the serum and brain regions, and higher neuroplasticity and hyperlocomotion in latter adulthood. Taken together, our results illustrate the non‐oncogenic functions of human TIAM2S and demonstrate that TIAM2S is a novel regulator of serotonin level, brain neuroplasticity, and locomotion behavior.

TIAM2S as a novel regulator for serotonin level enhances brain plasticity and locomotion behavior